Cargando…

Usefulness of Measuring Thiopurine Metabolites in Children with Inflammatory Bowel Disease and Autoimmunological Hepatitis, Treated with Azathioprine

INTRODUCTION: Thiopurines, such as azathioprine (AZA) and 6-mercaptopurine (6-MP), are immunomodulatory agents, used for the maintenance of remission in children with inflammatory bowel disease (IBD)—Crohn's disease (CD) and ulcerative colitis (UC), as well as with autoimmunological hepatitis (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bąk-Drabik, Katarzyna, Adamczyk, Piotr, Duda-Wrońska, Justyna, Dąbrowska-Piechota, Dominika, Jarzumbek, Anna, Kwiecień, Jarosław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233083/ https://www.ncbi.nlm.nih.gov/pubmed/34239556 http://dx.doi.org/10.1155/2021/9970019

Ejemplares similares

Pulmonary Function in Paediatric Patients with Inflammatory Bowel Disease
por: Bąk-Drabik, Katarzyna, et al.
Publicado: (2022)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Apoptosis in Autoimmunological Diseases, with Particular Consideration of Molecular Aspects of Psoriasis
por: Krawczyk, Agata, et al.
Publicado: (2020)

Various types of autoimmunological diseases of thyroid gland
por: Sporny, Stanisław
Publicado: (2013)

Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel Disease
por: Jonason, David E, et al.
Publicado: (2020)

Thiopurine S-Methyltransferase Polymorphisms Predict Hepatotoxicity in Azathioprine-Treated Patients with Autoimmune Diseases
por: Sheu, Heh-Shiang, et al.
Publicado: (2022)

Serologic autoimmunologic parameters in women with primary ovarian insufficiency
por: Zhen, Xiumei, et al.
Publicado: (2014)

Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease
por: Parkar, Suruchi P, et al.
Publicado: (2017)

Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity
por: Daniel, Laura L., et al.
Publicado: (2022)

Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2014)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

ZAG (Zinc-Alpha 2 Glycoprotein) Serum Levels in Girls with Anorexia Nervosa
por: Anna, Jarzumbek, et al.
Publicado: (2023)

Association of thiopurine S-methyltransferase and NUDT15 polymorphisms with azathioprine-induced myelotoxicity in Chinese patients with rheumatological disease
por: Su, Song-Sen, et al.
Publicado: (2020)

Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory
por: Tozzoli, Renato, et al.
Publicado: (2012)

Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
por: Gazouli, Μaria, et al.
Publicado: (2012)

Real-World Use of Azathioprine Metabolites Changes Clinical Management of Inflammatory Bowel Disease
por: Wilson, Laura, et al.
Publicado: (2020)

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease
por: Suzuki, Shizuka, et al.
Publicado: (2023)

Use of thiopurines in inflammatory bowel disease: an update
por: Singh, Arshdeep, et al.
Publicado: (2022)

The Effect of Music as a Non-Pharmacological Intervention on the Physiological, Psychological, and Social Response of Patients in an Intensive Care Unit
por: Lorek, Magdalena, et al.
Publicado: (2023)

Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease
por: Holt, Darcy Q, et al.
Publicado: (2016)

Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study
por: Jagt, Jasmijn Z., et al.
Publicado: (2021)

Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in Singapore
por: Yeo, Jia Qi, et al.
Publicado: (2022)

Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis
por: Liu, Yue-Ping, et al.
Publicado: (2015)

Bone marrow inhibition induced by azathioprine in a patient without mutation in the thiopurine S-methyltransferase pathogenic site: A case report
por: Zhou, Xiao-Shuang, et al.
Publicado: (2021)

Postprandial Abdominal Pain Caused by Gastroptosis—A Case Report
por: Staszewska, Anna, et al.
Publicado: (2023)

Thiopurines’ Metabolites and Drug Toxicity: A Meta-Analysis
por: Sousa, Paula, et al.
Publicado: (2020)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
por: Zakerska-Banaszak, Oliwia, et al.
Publicado: (2022)

Gene Expression and Thiopurine Metabolite Profiling in Inflammatory Bowel Disease – Novel Clues to Drug Targets and Disease Mechanisms?
por: Haglund, Sofie, et al.
Publicado: (2013)

Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease
por: Barnes, Alex, et al.
Publicado: (2022)

Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study
por: Fangbin, Zhang, et al.
Publicado: (2016)

Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all?
por: Walker, Rebecca, et al.
Publicado: (2019)

Autoimmunological serum parameters and bone mass density in premature ovarian insufficiency: a retrospective cohort study
por: Beitl, Klara, et al.
Publicado: (2020)

Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
por: Cococcioni, Lucia, et al.
Publicado: (2022)

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity
por: Teich, Niels, et al.
Publicado: (2016)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Azathioprine in inflammatory bowel disease, a safe alternative?
por: Tanis, A A
Publicado: (1998)

Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2013)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
por: Liu, Yue-Ping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6qaebs8d2afppf6283ptcndvkd